{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T16:46:28Z","timestamp":1754153188287,"version":"3.41.2"},"reference-count":19,"publisher":"Oxford University Press (OUP)","issue":"7","license":[{"start":{"date-parts":[[2025,6,24]],"date-time":"2025-06-24T00:00:00Z","timestamp":1750723200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,7,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Introduction<\/jats:title>\n                  <jats:p>Anti-phospholipid syndrome is characterized by venous and\/or arterial thrombosis in the presence of anti-phospholipid antibodies. We report a rare and dramatic manifestation of the syndrome: thrombotic coronary occlusion leading to myocardial infarction, resulting in multiple intra-LV thrombi responsible for multisystemic embolization.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Case presentation<\/jats:title>\n                  <jats:p>We report the case of a 38-year-old Caucasian woman, who presented to the emergency department with acute chest pain. On initial clinical examination, the patient was tachycardiac at 123\u2005b.p.m. with a correct blood pressure of 127\/69\u2005mmHg. The electrocardiogram showed sinus tachycardia at 125 b.p.m. with QS waves in the anteroseptal with persistent ST-segment elevation in the same territory. Transthoracic echocardiography revealed left ventricle ejection fraction of 35% with several intra-left ventricular (LV) thrombi. Troponin Ic was elevated at 5668\u2005ng\/L. The diagnosis of myocardial infarction was suspected and the patient was treated as such. Eight hours after admission, the patient presented with an embolization to both common femoral arteries which was treated by Fogarty embolectomy. The patient underwent coronary angiography, which revealed thrombotic occlusion of the proximal left anterior descending artery. A cerebro-thoraco-abdomino-pelvic computed tomography scan found a right renal infarct and a splenic infarct. Lab tests revealed positive anti-cardiolipin antibodies. Anti-phospholipid syndrome was confirmed and the patient was treated using aspirin and vitamin K antagonists. The evolution was marked by complete resolution of LV thrombi and the patient is actually asymptomatic apart from a slight exertional dyspnoea.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>Anti-phospholipid syndrome is an autoimmune disorder whose complications can be life-threatening and\/or functionally disabling. Arterial thrombosis can cause dramatic complications.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/ehjcr\/ytaf296","type":"journal-article","created":{"date-parts":[[2025,6,28]],"date-time":"2025-06-28T22:20:33Z","timestamp":1751149233000},"source":"Crossref","is-referenced-by-count":0,"title":["An ST elevation myocardial infarction with multisystemic embolization: a shocking and striking first presentation of antiphospholipid syndrome: a case report"],"prefix":"10.1093","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5470-559X","authenticated-orcid":false,"given":"Meryem","family":"Haboub","sequence":"first","affiliation":[{"name":"Cardiology Department, University Hospital Ibn Rochd , 8, street Lahcen El Arjoun, 20100 Casablanca ,","place":["Morocco"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ilyas","family":"Atlas","sequence":"additional","affiliation":[{"name":"Cardiology Department, University Hospital Ibn Rochd , 8, street Lahcen El Arjoun, 20100 Casablanca ,","place":["Morocco"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdenasser","family":"Drighil","sequence":"additional","affiliation":[{"name":"Cardiology Department, University Hospital Ibn Rochd , 8, street Lahcen El Arjoun, 20100 Casablanca ,","place":["Morocco"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0523-5373","authenticated-orcid":false,"given":"Rachida","family":"Habbal","sequence":"additional","affiliation":[{"name":"Cardiology Department, University Hospital Ibn Rochd , 8, street Lahcen El Arjoun, 20100 Casablanca ,","place":["Morocco"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2025,6,24]]},"reference":[{"key":"2025072211113585800_ytaf296-B1","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1538-7836.2006.01753.x","article-title":"International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)","volume":"4","author":"Miyakis","year":"2006","journal-title":"J Thromb Haemost"},{"key":"2025072211113585800_ytaf296-B2","doi-asserted-by":"crossref","first-page":"SI24","DOI":"10.1093\/rheumatology\/kead571","article-title":"Epidemiology of antiphospholipid syndrome: macro- and microvascular manifestations","volume":"63","author":"Gaspar","year":"2024","journal-title":"Rheumatology (Oxford)"},{"key":"2025072211113585800_ytaf296-B3","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1136\/annrheumdis-2013-204838","article-title":"Morbidity and mortality in the antiphospholipid syndrome during a 10-year period: a multicentre prospective study of 1000 patients","volume":"74","author":"Cervera","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"2025072211113585800_ytaf296-B4","first-page":"e17002","article-title":"Unraveling the association between myocardial infarction of nonobstructive coronary arteries and antiphospholipid syndrome","volume":"13","author":"Ramjas","year":"2021","journal-title":"Cureus"},{"key":"2025072211113585800_ytaf296-B5","doi-asserted-by":"crossref","first-page":"6","DOI":"10.33963\/KP.15090","article-title":"Antiphospholipid syndrome and the risk of myocardial infarction: current evidence and uncertainties","volume":"78","author":"L\u00f3czi","year":"2020","journal-title":"Kardiol Pol"},{"key":"2025072211113585800_ytaf296-B6","doi-asserted-by":"crossref","first-page":"129","DOI":"10.14740\/cr661w","article-title":"Coronary artery thromboses, stent thrombosis and antiphospholipid antibody syndrome: case report","volume":"9","author":"Correia","year":"2018","journal-title":"Cardiol Res"},{"key":"2025072211113585800_ytaf296-B7","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/0002-9343(94)90108-2","article-title":"Comparison of the primary and secondary antiphospholipid syndrome: a European Multicenter Study of 114 patients","volume":"96","author":"Vianna","year":"1994","journal-title":"Am J Med"},{"key":"2025072211113585800_ytaf296-B8","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1002\/art.10187","article-title":"Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients","volume":"46","author":"Cervera","year":"2002","journal-title":"Arthritis Rheum"},{"key":"2025072211113585800_ytaf296-B9","doi-asserted-by":"crossref","first-page":"621270","DOI":"10.1155\/2014\/621270","article-title":"Cardiovascular risk factors in the antiphospholipid syndrome","volume":"2014","author":"Da Silva","year":"2014","journal-title":"J Immunol Res"},{"key":"2025072211113585800_ytaf296-B10","doi-asserted-by":"crossref","first-page":"13","DOI":"10.4314\/pamj.v8i1.71062","article-title":"Acute myocardial infarction in young adults with antiphospholipid syndrome: report of two cases and literature review","volume":"8","author":"Abid","year":"2011","journal-title":"Pan Afr Med J"},{"key":"2025072211113585800_ytaf296-B11","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1191\/0961203303lu391oa","article-title":"Cardiac disease in the antiphospholipid syndrome: recommendations for treatment. Committee consensus report","volume":"12","author":"Lockshin","year":"2003","journal-title":"Lupus"},{"key":"2025072211113585800_ytaf296-B12","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1056\/NEJMoa035241","article-title":"A comparison of two intensities of warfarin for the prevention of recurrent thrombosis in patients with the antiphospholipid antibody syndrome","volume":"349","author":"Crowther","year":"2003","journal-title":"N Engl J Med"},{"key":"2025072211113585800_ytaf296-B13","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1159\/000338347","article-title":"Long-term outcome of patients with antiphospholipid syndrome who undergo percutaneous coronary intervention","volume":"122","author":"Perl","year":"2012","journal-title":"Cardiology"},{"key":"2025072211113585800_ytaf296-B14","first-page":"755","article-title":"Antithrombotic therapy management in a man with ST elevation myocardial infarction and triple positive antiphospholipid syndrome: case report and literature review","volume":"26","author":"Prandi","year":"2022","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"2025072211113585800_ytaf296-B15","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1001\/jama.295.9.1050","article-title":"Management of antiphospholipid antibody syndrome: a systematic review","volume":"295","author":"Lim","year":"2006","journal-title":"JAMA"},{"key":"2025072211113585800_ytaf296-B16","doi-asserted-by":"crossref","first-page":"e001678","DOI":"10.1136\/rmdopen-2021-001678","article-title":"Direct oral anticoagulants versus vitamin K antagonists in patients with antiphospholipid syndrome: systematic review and meta-analysis","volume":"7","author":"Koval","year":"2021","journal-title":"RMD Open"},{"key":"2025072211113585800_ytaf296-B17","doi-asserted-by":"crossref","first-page":"16270","DOI":"10.3390\/ijms242216270","article-title":"Factor XI in carriers of antiphospholipid antibodies: elevated levels associated with symptomatic thrombotic cases, while low levels linked to asymptomatic cases","volume":"24","author":"Pag\u00e1n-Escribano","year":"2023","journal-title":"Int J Mol Sci"},{"key":"2025072211113585800_ytaf296-B18","doi-asserted-by":"crossref","first-page":"17103","DOI":"10.1038\/nrdp.2017.103","article-title":"Antiphospholipid syndrome","volume":"4","author":"Schreiber","year":"2018","journal-title":"Nat Rev Dis Primers"},{"key":"2025072211113585800_ytaf296-B19","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.autrev.2013.11.004","article-title":"Risk of venous and arterial thrombosis according to type of antiphospholipid antibodies in adults without systemic lupus erythematosus: a systematic review and meta-analysis","volume":"13","author":"Reynaud","year":"2014","journal-title":"Autoimmun Rev"}],"container-title":["European Heart Journal - Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ehjcr\/advance-article-pdf\/doi\/10.1093\/ehjcr\/ytaf296\/63561615\/ytaf296.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ehjcr\/article-pdf\/9\/7\/ytaf296\/63561615\/ytaf296.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ehjcr\/article-pdf\/9\/7\/ytaf296\/63561615\/ytaf296.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,22]],"date-time":"2025-07-22T15:11:47Z","timestamp":1753197107000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ehjcr\/article\/doi\/10.1093\/ehjcr\/ytaf296\/8172109"}},"subtitle":[],"editor":[{"given":"Josip Andelo","family":"Borovac","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]},{"given":"Ahmed Mohamed","family":"Abdalwahab","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]},{"given":"Edin","family":"Begic","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]},{"given":"Reshma","family":"Amin","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2025,6,24]]},"references-count":19,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,7,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ehjcr\/ytaf296","relation":{},"ISSN":["2514-2119"],"issn-type":[{"type":"electronic","value":"2514-2119"}],"subject":[],"published-other":{"date-parts":[[2025,7]]},"published":{"date-parts":[[2025,6,24]]},"article-number":"ytaf296"}}